TIDMDVRG
RNS Number : 7362P
Deepverge PLC
21 October 2021
21 October 2021
DeepVerge PLC
("DeepVerge" or "Company")
Second Generation Microtox(R) PD[i] pandemic response equipment
shipping to UK, China and India
Modern Water, a division of DeepVerge (AIM: DVRG) announces
GBP2.2m worth of new orders for newly enhanced monitoring equipment
with upgraded software which are being shipped to the UK, India and
China to meet customer and partner obligations for delivery in this
financial year.
Initial shipments of Pandemic Response Equipment
The shipments include upgraded Microtox(R) toxicity monitoring,
new models of the Microtox(R) PD range for SARS-CoV-2 and other
pathogen monitoring as well as Microsaic mass spectrometer
equipment to monitor forever chemicals and contaminants of emerging
concern.
New software, data management capability, dashboards,
encryption, and new AI models are fully integrated as part of the
shipped solutions that offer three levels of surveillance:
1. Traditional pollution - toxicity and heavy metals
2. Pandemic surveillance, and
3. PFASs - "Forever Chemicals" (Per- and Polyfluoroalkyl Substances)
Gerry Brandon CEO of DeepVerge plc commented:
"Just 11 months following the Modern Water acquisition,
DeepVerge is shipping 2(nd) generation real-time pandemic response
equipment with SARS-CoV-2 detection fully integrated to meet
initial customer demand after the successful demonstration of Phase
III field trials announced in our RNS[ii] of 24 June 2021.
"The success of the DeepVerge new product division, based in
York, UK and Cork, Ireland, is a credit to the teams working across
the Group who have delivered more than could have been hoped for
when we announced the data science, physics and epidemiology centre
of excellence in the RNS[iii] of 6 May 2021. As a result, we now
have upgraded Microtox equipment with the capability to monitor
COVID-19 in real-time and other pathogens as well as pollutants,
being shipped across three continents."
DeepVerge New Product Development in Cork, Ireland
The equipment was assembled in DeepVerge's product development
facility in Cork, Ireland which has been up and running for the
past six months. The new generation of Modern Water surveillance
solutions also come with enhanced data generation capability and AI
learning that allows added value extrapolation of data being
delivered in real-time.
This new facility gives DeepVerge control of final assembly and
Quality Assurance as well as providing a world serving logistics
centre that includes the EU, China, and India with delivery of the
solutions to national and provincial government and state
controlled utilities. It will play a vital part in the worldwide
supply chain being developed with existing partners and develop new
manufacturing partnerships in China.
While the software solution that is incorporated for this
generation of equipment is packaged and COTS (commercial off the
shelf), all data generated by customers and partners in-country
equipment is encrypted to military grade standard and remains
in-country in recognition that the customer or sovereign state owns
the data, which is important with health data as it is increasingly
regarded as a national bio security matter.
Enquiries:
+44 (0) 734 0055
DeepVerge plc Gerry Brandon, CEO 648
SPARK Advisory Partners
Limited
(Nominated Adviser) Neil Baldwin +44 (0) 113 370 8974
Turner Pope Investments
(TPI) Limited Andy Thacker/James
(Broker) Pope +44 (0) 20 3657 0050
Market Abuse Regulation (MAR) Disclosure
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of
companies that develops and applies AI and IoT technology to
analytical instruments for the analysis and identification of
bacteria, virus and toxins. Utilising artificial intelligent data
analytics to scientifically prove the impact of skincare product
claims on skin microbiome for most of the top 20 global cosmetic
company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water,
rivers, lakes and reservoirs.
About Microsaic
Microsaic listed on AIM in 2011 to develop and commercialise
micro-engineering chip-based mass spectrometry equipment. Having
invested GBP30m over the last 20 years before and after the IPO,
Microsaic has a robust patent portfolio in cutting-edge technology
purpose built for "Industry 4.0" which enables analytical detection
and characterisation at the point-of-need, whether within a human
health environment, conventional laboratory setting, or within a
bioprocessing facility for continuous mass spectrometer detection
and monitoring of data at any step in the process workflow.
[i] Microtox(R) PD has been designed to be retrofitted into
existing Modern Water equipment to detect and identify a range of
infectious viruses and bacteria including SARS-CoV-2, E.coli,
Legionella and Cryptosporidium, on a single chip, using AI, in
real-time
[ii]
https://www.londonstockexchange.com/news-article/DVRG/microtox-successful-phase-3-field-trials/15030475
[iii]
https://www.londonstockexchange.com/news-article/DVRG/new-ai-centre-of-excellence-in-cork/14965354
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEAPEEADEFFFA
(END) Dow Jones Newswires
October 21, 2021 02:00 ET (06:00 GMT)
Integumen (LSE:SKIN)
Historical Stock Chart
From Apr 2024 to May 2024
Integumen (LSE:SKIN)
Historical Stock Chart
From May 2023 to May 2024